Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 455

Results For "MED"

5371 News Found

Alarming rise in diabetes amongst children and adolescents in India
News | November 14, 2021

Alarming rise in diabetes amongst children and adolescents in India

The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue


Jubilant HollisterStier plans US $92 mn expansion
News | November 13, 2021

Jubilant HollisterStier plans US $92 mn expansion

The 50,000 square foot expansion will house a high-speed filling line and lyophilizers, which will increase the facility’s sterile injectable capacity by 50%


Moderna presents data from Phase 1 study of mRNA Triplet programme
Biotech | November 13, 2021

Moderna presents data from Phase 1 study of mRNA Triplet programme

The interim data combines three mRNAs into one therapy injected directly into the tumour


European Commission approves Ronapreve to treat Covid-19
Drug Approval | November 13, 2021

European Commission approves Ronapreve to treat Covid-19

Data demonstrates Ronapreve reduced risk of hospitalisation in certain patients and reduced risk of symptomatic Covid-19 infections in people exposed to the virus


Thermo Fisher to set up manufacturing facility in Mebane N.C.
Medical Device | November 13, 2021

Thermo Fisher to set up manufacturing facility in Mebane N.C.

The US $ 192.5 mn US government contract will help fund the centre of excellence to boost the domestic supply of critically needed laboratory plastics


Aster DM Healthcare PAT at Rs 107 cr. in Q2FY22
News | November 13, 2021

Aster DM Healthcare PAT at Rs 107 cr. in Q2FY22

Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021


Natco Pharma PAT at Rs 65.1 cr. in Q2FY22
News | November 12, 2021

Natco Pharma PAT at Rs 65.1 cr. in Q2FY22

Natco Pharma has reported consolidated financial results for the period ended September 30, 2021


Meridian Bioscience receives U.S. FDA Emergency Use Authorization for Revogene SARS-CoV-2 molecular assay
Biotech | November 12, 2021

Meridian Bioscience receives U.S. FDA Emergency Use Authorization for Revogene SARS-CoV-2 molecular assay

The company expects to begin shipping this product before the end of its fiscal first quarter, ending December 31, 2021


World’s first Whole Genome Sequencing study uncovers new and potential therapies
News | November 12, 2021

World’s first Whole Genome Sequencing study uncovers new and potential therapies

The ground-breaking project, led by Genomics England and NHS England, was established in 2013 to sequence 100,000 whole genomes from NHS patients and their families


Ronapreve gets the green light from CHMP to treat non-hospitalised Covid-19 patients
Biotech | November 12, 2021

Ronapreve gets the green light from CHMP to treat non-hospitalised Covid-19 patients

A final decision regarding the approval of Ronapreve is expected from the European Commission shortly